ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P ASX 200
8,250.50
0.60%
S&P ASX All Technology
3,828.50
0.37%
Brent Oil
76.495
0.00%
US Dollar vs AUD
1.60849
0.00%
Bitcoin
97,837.86
-0.38%
Pepperstone
Advertisement
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. UK
  5. LSE

  6. Andrews Sykes Group Plc (ASY) Share Price

Andrews Sykes Group Plc

Andrews Sykes Group Plc (ASY)

Assystem
520.00
5.00
(0.97%)
Closed 05 January 3:30AM
Delayed by 15 minutes

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Key stats and details

Current Price
520.00
Bid
510.00
Offer
530.00
Volume
201
515.00 Day's Range 520.00
494.00 52 Week Range 640.00
Market Cap
217.665M
Previous Close
515.00
Open
515.00
Last Trade
142
@
523.4
(O)
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
1,653
Shares Outstanding
41,858,744
Dividend Yield
4.98%
PE Ratio
12.26
Earnings Per Share (EPS)
0.42
Revenue
78.75M
Net Profit
17.76M

About Andrews Sykes Group Plc

Sector
Air Heat & Condition Eq-whsl
Industry
Indl,comml Machy,computer Eq
Headquarters
, Gbr
Founded
1921
Andrews Sykes Group Plc is listed in the Air Heat & Condition Eq-whsl sector of the London Stock Exchange with ticker ASY. The last closing price for Andrews Sykes was 515p. Over the last year, Andrews Sykes shares have traded in a share price range of 494.00p to 640.00p.

Andrews Sykes currently has 41,858,744 shares in issue. The market capitalisation of Andrews Sykes is £215.57 million. Andrews Sykes has a price to earnings ratio (PE ratio) of 12.26.

Ask ADVFN Intelligence (AI)

ASY Latest News

More News

Andrews Sykes Group PLC Change of NOMAD

Andrews Sykes Group PLC 01 October 2024   1 October 2024   Andrews Sykes Group PLC (the "Company") Change of Nominated Adviser   As a consequence of an internal reorganisation within the...

01 October 2024
RNS Regulatory News

EARNINGS: Dekel Agri-Vision posts loss; Big Technologies profit falls

The following is a round-up of earnings for London-listed companies, issued on Wednesday and not separately reported ...

25 September 2024
Alliance News

Andrews Sykes Group PLC Half Year Report

Andrews Sykes Group PLC 25 September 2024     25 September 2024                                                                                                                      ANDREWS...

25 September 2024
RNS Regulatory News

Andrews Sykes Group PLC Result of AGM

Andrews Sykes Group PLC 18 June 2024   18 June 2024   ANDREWS SYKES GROUP PLC ("Andrews Sykes" or the "Company") Result of AGM Andrews Sykes is pleased to announce that at its Annual General...

19 June 2024
RNS Regulatory News

Andrews Sykes Group PLC Posting of Annual Report and Notice of AGM

Andrews Sykes Group PLC 13 May 2024   13 May 2024   Andrews Sykes Group PLC ("Andrews Sykes" or the "Company") Posting of Annual Report and Notice of AGM Andrews Sykes announces that its...

13 May 2024
RNS Regulatory News

EARNINGS: International Biotechnology bullish; Andrews Sykes profit up

The following is a round-up of earnings for London-listed companies, issued on Wednesday and not separately reported ...

08 May 2024
Alliance News

Andrews Sykes Group PLC Preliminary Result

Andrews Sykes Group PLC 08 May 2024     8 May 2024   ANDREWS SYKES GROUP PLC ("Andrews Sykes" or "the Company" or "the Group")   Final Results for the year ended 31 December 2023   Summary of...

08 May 2024
RNS Regulatory News

Andrews Sykes Group PLC Change of Name of Nominated Advisor - Replacement

Andrews Sykes Group PLC 04 March 2024   The headline for the Andrews Sykes Group PLC announcement released on 4/3/2024 at 09:12am under RNS No 4438F should read Change of Name of Nominated...

04 March 2024
RNS Regulatory News

Andrews Sykes Group PLC Change of Name

Andrews Sykes Group PLC 04 March 2024   4 March 2024   Andrews Sykes Group PLC ("Andrews Sykes" or the "Company") Change of name of Nominated Adviser   The Company has been notified that, as a...

04 March 2024
RNS Regulatory News

IN BRIEF: Andrew Sykes promotes non-executive chair to executive chair

up PLC - Wolverhampton-based heating and air-conditioning firm - Promotes Non-Executive Chair Jean-Jacques Murray to e ...

12 February 2024
Alliance News
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
123.54.73313192346496.5520496.52722510.45812288DE
413.52.66535044423506.55204942169504.3978878DE
12-12.5-2.34741784038532.55404941653513.95903136DE
26-30-5.454545454555505954941618537.72905855DE
52-107.5-17.1314741036627.56404941915564.23216706DE
156255.05050505051495767.54551906556.5059992DE
260-100-16.1290322581620767.53551767550.43028213DE

ASY - Frequently Asked Questions (FAQ)

What is the current Andrews Sykes share price?
The current share price of Andrews Sykes is 520.00p
How many Andrews Sykes shares are in issue?
Andrews Sykes has 41,858,744 shares in issue
What is the market cap of Andrews Sykes?
The market capitalisation of Andrews Sykes is GBP 215.57M
What is the 1 year trading range for Andrews Sykes share price?
Andrews Sykes has traded in the range of 494.00p to 640.00p during the past year
What is the PE ratio of Andrews Sykes?
The price to earnings ratio of Andrews Sykes is 12.26
What is the cash to sales ratio of Andrews Sykes?
The cash to sales ratio of Andrews Sykes is 2.76
What is the reporting currency for Andrews Sykes?
Andrews Sykes reports financial results in GBP
What is the latest annual turnover for Andrews Sykes?
The latest annual turnover of Andrews Sykes is GBP 78.75M
What is the latest annual profit for Andrews Sykes?
The latest annual profit of Andrews Sykes is GBP 17.76M
What is the registered address of Andrews Sykes?
The registered address for Andrews Sykes is UNIT 601, AXCESS 10 BUSINESS PARK BENTLEY ROAD SOUTH, WEDNESBURY, WS10 8LQ
Which industry sector does Andrews Sykes operate in?
Andrews Sykes operates in the INDL,COMML MACHY,COMPUTER EQ sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
TCFTheracryf Plc
0.725p
(38.10%)
7.56M
NMTNeometals Ltd
3.50p
(27.27%)
346.81k
SCHOScholium Group Plc
44.00p
(25.71%)
30.65k
FABFusion Antibodies Plc
10.15p
(24.54%)
3.34M
PYXPyx Resources Limited
3.49p
(22.24%)
8.43k
TM1Technology Minerals Plc
0.125p
(-24.24%)
37.21M
QUIZQuiz Plc
0.70p
(-18.60%)
3.67M
SYMESupply@me Capital Plc
0.003p
(-17.81%)
168.35M
OBDOxford Biodynamics Plc
1.20p
(-14.29%)
827.83k
ZENZenith Energy Ltd.
5.25p
(-13.93%)
5.39M
TRPTower Resources Plc
0.0395p
(5.33%)
539.51M
CPXCap-xx Limited
0.1825p
(1.39%)
494M
NTVONativo Resources Plc
0.0019p
(0.00%)
320.16M
DGIDg Innovate Plc
0.0225p
(-13.46%)
208.21M
ENETEthernity Networks Ltd
0.1125p
(2.27%)
207.56M

Discussion

View Full Feed
CanItBThisEZ2Make CanItBThisEZ2Make 2 minutes ago
BEST SELLERS RANK (BSR) IS 756 3 Estimated Sold on Amazon Since JAN 1 - 1ST Quarter 2025
https://investorshub.advfn.com/uimage/uploads/2024/4/24/cnxttVOS_5G_GIF.gif
https://www.amazon.com/Vos-RDGL5GX55-B-01-VOS-5G-Dongle/dp/B0C66KHZLP

NOTE: In theory, when BSR Value Decr
SRMX
cottonisking cottonisking 4 minutes ago
🗼🗽Category Description of tasks
Tax and VAT
Work reported in this category includes
compliance with tax legislation under
the Administrators’ obligations as proper
officers for tax, and planning to ensure
the efficient realisation of assets f
MCF
eagle8 eagle8 4 minutes ago
Tommy Bax 🇬🇧 🇹🇼
@TommyBaxendale
·
13h
Replying to
@GoneGoodguy
Further to my other tweet above, I can confirm that none of the seemingly key researchers working on the Imperial College London BioNtech mRNA cancer vaccine (Pol
NWBO
eagle8 eagle8 17 minutes ago
Peter Davis
@peter_brit
#dcvax $nwbo #gbm

FDA Signals potential for standard approval of Paxalisib in Glioblastoma - AI Analysis (Gemini) of possible implications for FDA approval of #dcvax

The FDA's decision regarding paxalisib in glioblastoma (GBM) pro
NWBO
Iggy_Bot Iggy_Bot 19 minutes ago
Im so happy dems are doing stuff like this, Nevada should be red for a long time now
and between the people of the state and Trump i would bet it will be over turned,
ElectricMountain53 ElectricMountain53 28 minutes ago
What Lebby said has got no value anymore. He also said deals were around the corner and many other things that haven´t come to fruition. Now he´s fired.
Let´s just wait what Yves has to say next week!!
You posting so much seems like pumping before the 9th!
Are you afraid of wh
LWLG
igotthemojo igotthemojo 51 minutes ago
i am speaking as the foremost authority on kblb that there is...bar none...i am saying that this stock is ready to fly...and will start flying BEFORE Feb...i have spoken...
KBLB
nowwhat2 nowwhat2 54 minutes ago
The Total 3

https://investorshub.advfn.com/uimage/uploads/2025/1/5/twljxtotal_3_!_5_5d_1212am_whump.jpg



Sho nuff.......Whump......Much of this is XRP but I'll betcya Doge, etc. SOL, too

https://investorshub.advfn.com/uimage/uploads/2025/1/
XRPUSD
boi568 boi568 1 hour ago
That spike to $31.50 was not organic and it was clearly generated by a big player. I have always thought it was an engineered mini-short squeeze.
AVXL
Mr. Bill Mr. Bill 1 hour ago
https://www.goodrx.com/well-being/sleep/how-to-sleep-with-sciatica
nowwhat2 nowwhat2 1 hour ago
Could still just be climbing in sympathy w overall crypto mkt

Scathingly poor outlooks

https://www.youtube.com/watch?v=EOsjnOUAw14



https://investorshub.advfn.com/uimage/uploads/2025/1/5/siwcoTOTAL_3_!_4_3M_JUNCT_DAY_1.jpg

WONDF
DonVance DonVance 1 hour ago
This will hit 1k this year I believe now.
MSTR
georgejjl georgejjl 1 hour ago
How many of the 7 million Alzheimer’s patients in the USA are projected to be treated with the MAB infusions during 2025???

How many people with Alzheimer’s in the USA are projected to be treated with donepezil (Aricept) or memantine during 2025???

The treatment used t
AVXL
Mr. Bill Mr. Bill 1 hour ago
Stretches https://www.healthline.com/health/back-pain/sciatic-stretches#sitting-spinal-stretch
Graniteguy Graniteguy 1 hour ago
Doc and Investor posters here tend to be negatively biased which you whole heartedly champion, especially "Doc" who's medical opinion is at best questionable, and incredibly biased, to fit a narrative of constant failure for Anavex's Blarcamesine. The fact that you pile onto their "steaming pile of
AVXL
BDEZ BDEZ 1 hour ago
The Russes hit the jackpot?
BDEZ BDEZ 1 hour ago
40% of homicides in the US take place in districts with a Soros-funded prosecutor.

Biden gave him a Medal Of Freedom.

https://x.com/EndWokeness/status/1875725808071012529
BDEZ BDEZ 1 hour ago
Not good, thanks for sharing.
sand sand 1 hour ago
Thank you Ducci for all your sharing and insights extremely helpful. I'm slowly diligently getting there rewiring the brain and focusing on what shows the moves. Much continued success this week. Thank you again.
SPY
mining101 mining101 1 hour ago
Moving hard soon 
EFSH
mining101 mining101 2 hours ago
Superb
MEGL
benz280c benz280c 2 hours ago
Speak louder and maybe you will convince somebody that this is how you really feel. No need to be insecure around your fellow investors.
GDVM
rx7171 rx7171 2 hours ago
In addition MABs are approved for only a limited portion of the AD population, whereas Blarcamasine appears to be effective in 70-80% of the ITT population with its strongest efficacy in the 70% with wild type Sigma-1.
AVXL

Your Recent History

LSE
ASY
Andrews Sykes
NASDAQ
AAPU
Direxion Daily AAPL Bull...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads